FDA Inspection 1097497 — Harpreet Bajaj, M.D.
The FDA completed an inspection of Harpreet Bajaj, M.D. on Jul 3, 2019 in Brampton. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 3, 2019
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Brampton (Canada)
Additional details
Clinical Investigator (CI)